Archive for July, 2009

FDA approves new drug treatment for type 2 diabetes

Friday, July 31st, 2009

The U.S. Food and Drug Administration on Friday approved Onglyza, a once-daily tablet to treat Type 2 diabetes in adults. (Source: Xinhuanet Chinaview Health)

Obesity surgery death rates are low, study finds

Friday, July 31st, 2009

Obese, but worried that surgery for it might kill you? The risk of that has dropped dramatically, and now is no greater than ... (Source: USATODAY.com Health)

FDA Approves ONGLYZA for the Treatment of Type 2 Diabetes in the US

Friday, July 31st, 2009

AstraZeneca and Bristol-Myers Squibb today announced that the US Food and Drug Administration (FDA) has approved ONGLYZA (saxagliptin) for the treatment of type 2 diabetes mellitus in adults. (Source: World Pharma News)

Even Small Weight Loss Helps in a Big Way

Friday, July 31st, 2009

Being overweight makes it harder to manage your diabetes. Extra pounds can effect how your body uses insulin. Fat cells are more resistant to insulin than muscle cells, so... (Source: About Diabetes)

Stronger support for breastfeeding benefits women and babies

Friday, July 31st, 2009

Breastfeeding promotion still lags far behind spend on formula milk marketingRelated items from OnMedicaChanges to health visiting service will put kids at risk Government launches its Child Health Strategy Obesity problems begin before conception Poorest Scottish kids do the least exerciseCash-injection for sick children (Source: OnMedica Latest News)

Successful Surgical Emergency Cricothyroidotomy on the Scene in a Patient With Severe Facial Trauma and Difficult Neck Anatomy

Friday, July 31st, 2009

Conclusion: Failure to establish a patent upper airway by non-surgical means is a rare complication in anesthesia and emergency care. In such a situation, where the oral and nasal route is impossible, cricothyroidotomy is a life-saving skill. Intimate familiarity with the technique and detailed practical knowledge of the anatomy are ...

FDA Approves Onglyza (saxagliptin) for Type 2 Diabetes

Friday, July 31st, 2009

ROCKVILLE, Md., July 31, 2009--The U.S. Food and Drug Administration today approved Onglyza (saxagliptin), a once-daily tablet to treat Type 2 diabetes in adults. The medication is intended to be used with diet and exercise to control high... (Source: Drugs.com - New Drug Approvals)

FDA Approves New DPP-4 Drug for Type 2 Diabetes

Friday, July 31st, 2009

WASHINGTON (MedPage Today) -- The FDA today approved saxagliptin (Onglyza) for type 2 diabetes treatment, making it the first gliptin-class competitor for sitagliptin (Januvia). (Source: MedPage Today Cardiovascular)

Anthropometric differences in preschool children of Japanese ancestry in Lima, Peru.

Friday, July 31st, 2009

Authors: Shimabuku R, Teruya A, Nakachi G Ethnic differences in the pattern and trend of growth and weight have been described in studies of migrant populations. Our objective was to compare anthropometric parameters and overweight prevalence in third and fourth generation Japanese descendant preschoolers within the Peruvian ...

Alcohol consumption is associated with decreased insulin resistance independent of body mass index in Japanese community-dwelling men.

Friday, July 31st, 2009

In conclusion, alcohol consumption is associated with decreased insulin resistance independent of BMI in Japanese community-dwelling men. PMID: 19638738 [PubMed - in process] (Source: The Tohoku Journal of Experimental Medicine)